Now we have research which reveals 1) the mechanism by which active EBV damages the myelin sheath and 2) the existence of vascular co-morbidity (CCSVI) which may accelerate handicap by 6 years. We also know that infection with Mononucleosis leads to these 2 MS factors by 1) causing EBV infection and 2) damaging the vascular system.
So we have a double imperative to treat active MS pathology. 1) Prevent active EBV infection by taking an anti-viral (We’ll call this smouldering MS. See IVERMECTIN)) 2) Treat CCSVI.
Eventually find treatments to repair damage to the CNS.
GOOD NEWS :
The anti viral Ivermectin is apparently effective in treating EBV, therefore MS .
I have found it non toxic and very inexpensive.
Check out the Gavin Giovannoni Video The Future of MS Therapy Vidéos de Gavin Giovannoni future of MS therapy after 48 minutes when he speaks of Vascular Comorbitity which can cause a disability gap of 6 years - enormous. It would seem perfectly legitimate to see if one has a vascular problem and treat if possible. This should help deal with the MS lobby-s resistance to see value in the CCSVI question. Prof Giovannoni mentions the arteries when he must know of the considerable work addressing venous anomolies. I am absolutely certain during an attack stress causes my veins to malfunction sending blood? into the CNS.. I am wary of venoplasty, prefer continuing with manual release of spasms in the vascular system. While maybe one third have enjoyed major relief through venoplasty, maybe a third minor improvement, one third none at all. There is always the danger of blood clots closing off the veins/ I don't want to risk being worse off after than before. I know one lady who was in heaven after venoplasty, but when she was obliged to cease blood thinner for another surgery, a blood clot closed off a jugular. I have not adequtely treated my self for the EBV. I keep in mind that the EBV re-activates in a low oxygen environment so keeping proper blood flow is essential to prevent EBV emergence. But I may take an anti viral when my spirits are low. Anyway, to head off scepticism about CCSVI I will emphasize VASCULAR CO MORBITITY which may be more prevalent than Dr Giovannoni thinks. Chinese researchers (and Dr Zamboni) have found blood flow problems in MS. I am convinced the more serious damage to CNS for me occurs during an "attack' of blood back jets, that the damage caused by "smoldering MS" is minimal by comparison.
bing.com/videos
The Future of Multiple Sclerosis Therapy
Aperçu
The Future of Multiple Sclerosis Therapy
54:28
The Future of Multiple Sclerosis Therapy
11,6K vues16 janv. 2023
YouTubeGavin Giovannoni
https://med.stanford.edu/news/all-news/ ... rosis.html
How Epstein-Barr virus triggers multiple sclerosis
Study identifies how Epstein-Barr virus triggers multiple sclerosis
A new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune system to mistakenly attack the body’s nerve cells.
See IVERMECTIN and Multiple Sclerosis - Anti-inflammatory action, neuroprotection and re-myelin
de : "Dr. William Makis from \"COVID Intel\"" <[email protected]>
Tags : Ivermectin, MS, Mononucleosis, EBV Epstein Barr Virus, CCSVI, Dr Makis, Dr Zamboni, Dr William Makis, Dr Gavin Giovannoni
So we have a double imperative to treat active MS pathology. 1) Prevent active EBV infection by taking an anti-viral (We’ll call this smouldering MS. See IVERMECTIN)) 2) Treat CCSVI.
Eventually find treatments to repair damage to the CNS.
GOOD NEWS :
The anti viral Ivermectin is apparently effective in treating EBV, therefore MS .
I have found it non toxic and very inexpensive.
Check out the Gavin Giovannoni Video The Future of MS Therapy Vidéos de Gavin Giovannoni future of MS therapy after 48 minutes when he speaks of Vascular Comorbitity which can cause a disability gap of 6 years - enormous. It would seem perfectly legitimate to see if one has a vascular problem and treat if possible. This should help deal with the MS lobby-s resistance to see value in the CCSVI question. Prof Giovannoni mentions the arteries when he must know of the considerable work addressing venous anomolies. I am absolutely certain during an attack stress causes my veins to malfunction sending blood? into the CNS.. I am wary of venoplasty, prefer continuing with manual release of spasms in the vascular system. While maybe one third have enjoyed major relief through venoplasty, maybe a third minor improvement, one third none at all. There is always the danger of blood clots closing off the veins/ I don't want to risk being worse off after than before. I know one lady who was in heaven after venoplasty, but when she was obliged to cease blood thinner for another surgery, a blood clot closed off a jugular. I have not adequtely treated my self for the EBV. I keep in mind that the EBV re-activates in a low oxygen environment so keeping proper blood flow is essential to prevent EBV emergence. But I may take an anti viral when my spirits are low. Anyway, to head off scepticism about CCSVI I will emphasize VASCULAR CO MORBITITY which may be more prevalent than Dr Giovannoni thinks. Chinese researchers (and Dr Zamboni) have found blood flow problems in MS. I am convinced the more serious damage to CNS for me occurs during an "attack' of blood back jets, that the damage caused by "smoldering MS" is minimal by comparison.
bing.com/videos
The Future of Multiple Sclerosis Therapy
Aperçu
The Future of Multiple Sclerosis Therapy
54:28
The Future of Multiple Sclerosis Therapy
11,6K vues16 janv. 2023
YouTubeGavin Giovannoni
https://med.stanford.edu/news/all-news/ ... rosis.html
How Epstein-Barr virus triggers multiple sclerosis
Study identifies how Epstein-Barr virus triggers multiple sclerosis
A new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune system to mistakenly attack the body’s nerve cells.
See IVERMECTIN and Multiple Sclerosis - Anti-inflammatory action, neuroprotection and re-myelin
de : "Dr. William Makis from \"COVID Intel\"" <[email protected]>
Tags : Ivermectin, MS, Mononucleosis, EBV Epstein Barr Virus, CCSVI, Dr Makis, Dr Zamboni, Dr William Makis, Dr Gavin Giovannoni
RSS Feed